TransMedics Group, Inc. (TMDX) Financials
TMDX Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 706.0 million | 568.8 million |
2023-09-30 | 689.2 million | 562.8 million |
2023-06-30 | 690.4 million | 545.1 million |
2023-03-31 | 287.1 million | 94.5 million |
TMDX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -33.5 million | 5.7 million |
2023-09-30 | -141.8 million | 5.2 million |
2023-06-30 | -7.2 million | 5.0 million |
2023-03-31 | -9.6 million | 3.9 million |
TMDX Net Income
No data available :(
TMDX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | - | - | 9.7 million |
2023-09-30 | 427.1 million | - | 10.2 million |
2023-06-30 | 582.2 million | - | 10.3 million |
2023-03-31 | 195.4 million | 58.8 million | 8.5 million |
TMDX Shares Outstanding
TMDX Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 41.8 million | 10.8 million | 34.6 million | - |
2023-09-30 | 134.9 million | 38.3 million | 30.7 million | - |
2023-06-30 | 1.4 million | 8.3 million | 27.9 million | 1.4 million |
2023-03-31 | 927000 | 5.9 million | 25.0 million | - |
TMDX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 81.2 million | 33.3 million |
2023-09-30 | 66.4 million | 25.8 million |
2023-06-30 | 52.5 million | 15.7 million |
2023-03-31 | 41.6 million | 12.8 million |
TMDX
Price: $94.13
52 week price:
Earnings Per Share: -0.77 USD
P/E Ratio: -79.52
Exchange: NGM
Sector: Healthcare
Industry: Medical Devices
Volume: 513900
Market Capitalization: 3.1 billion